By Dorothy Du IBM Creation “Watson” May Have the Potential to Assist in Legal Research Watson, an IBM super computer four years in the making, competed on the popular TV game show Jeopardy! on February 14 through 16. On the 16th, Watson prevailed against former Jeopardy! champions Ken Jennings and Brad Rutter, tallying in at a total of $77,147 in winnings — more than triple each human contestant’s totals, as PC World reports. Robert Weber, IBM’s senior vice president of legal ... Read More...
Archive for the ‘Food and Drug Administration’ Category
Class action claim against Zicam manufacturer Matrixx reinstated by the Ninth Circuit By Abby Lauer – Edited by Alissa Del Riego Siracusano v. Matrixx Initiatives, Inc., No. 06-15677 (9th Cir. Oct. 28, 2009) Opinion The Ninth Circuit has unanimously reversed the U.S. District Court for the District of Arizona’s holding, which had dismissed a class action claim against Zicam manufacturer Matrixx for the complaint’s failure to adequately allege a violation of the Private Securities Litigation Reform Act of 1995 (“PSLRA”). ... Read More...
By Sarah Sorscher*, JD/MPH Candidate, Harvard Law School & Sara Crager, MD/PhD Candidate, Yale Editorial Policy Text of H.R. 1427 Summary Last week, Rep. Henry Waxman and several other representatives unveiled the latest version of a bill designed to lower the price of drugs by encouraging generic competition in biological products (“biologics”). Biologics are products derived from living processes and used to prevent, treat, or cure human illness. Most drugs, in contrast, are synthesized using chemical reactions. Biologics include products such as vaccines, blood-derived products, antibodies, ... Read More...
Supreme Court Holds that FDA Regulation Does Not Preempt State Tort Claim By Caitlyn Ross – Edited by Miriam Weiler Wyeth v. Levine Supreme Court of the United States, March 4, 2009, No. 06-1249 Slip Opinion On March 4th, the Supreme Court of the United States affirmed the judgment of the Vermont Supreme Court, holding that federal drug labeling regulations do not preempt state failure-to-warn lawsuits. The Supreme Court held that compliance with FDA labeling requirements did not preempt Levine’s ... Read More...
